Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban

Thromb Haemost. 2025 Sep;125(9):821-824. doi: 10.1055/a-2510-6370. Epub 2025 Jan 7.

Mehrdad Zarghami^{1

2}, Sina Rashedi³, Gregory Piazza^{2

3}, Marie Denise Gerhard-Herman², Geoffrey D Barnes⁴, Behnood Bikdeli^{2

3

5}

¹ Department of Medicine, Jamaica Hospital Medical Center, Queens, New York, United States.
² Division of Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
³ Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
⁴ Frankel Cardiovascular Center, University of Michigan Ann Arbor, Michigan, United States.
⁵ YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.

No abstract available